Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Dendreon

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Dendreon's 2012 oncology sales performance.

Dendreon Corporation

BMS appoints new commercial leader, Davies joins Eisai and more

BMS appoints new commercial leader, Davies joins Eisai and more

He has also held a number of roles for Dendreon Corporation and Roche’s Genentech, where he worked on its Avastin franchise strategy.

Cancer immunotherapy: What's on the horizon?

Cancer immunotherapy: What's on the horizon? Vaccines. While the first therapeutic cancer vaccines have reached the market, eg Dendreon’s Provenge and Antigenics’ Oncophage, commercially they haven’t yet made much impact and the pipeline has been

Dendreon appoints new R&D lead

Dendreon appoints new R&D lead Cancer vaccine company Dendreon has added to its senior team, appointing Dr Bruce Brown as its new senior vice president, medical. ... Dr Brown’s new role will see him head the company’s R&D organisation, including research and discovery, clinical

Deal Watch January 2017

Deal Watch January 2017 Bringing in an additional $819.9m in cash, Valeant also sold its equity interest in Dendreon (manufacturer of Provenge, a personalised immunotherapy) to the Sanpower Group. ... Dendreon had only been acquired in February 2015 from bankruptcy for $495m

Valeant uncouples Dendreon and skincare brands to cut debt

Valeant uncouples Dendreon and skincare brands to cut debt Agrees deals worth $2.1bn with L’Oreal and Sanpower Group. Dendreon's Provenge cancer vaccine. ... cosmetics giant L'Oreal for $1.3bn and the Dendreon cancer vaccine business to China's Sanpower Group for around $820m.

1 2 3 4 5 6 7 8 9 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics